JP2006020648A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006020648A5 JP2006020648A5 JP2005271209A JP2005271209A JP2006020648A5 JP 2006020648 A5 JP2006020648 A5 JP 2006020648A5 JP 2005271209 A JP2005271209 A JP 2005271209A JP 2005271209 A JP2005271209 A JP 2005271209A JP 2006020648 A5 JP2006020648 A5 JP 2006020648A5
- Authority
- JP
- Japan
- Prior art keywords
- trt
- polypeptide
- antigen
- leukocytes
- consecutive amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 12
- 229920001184 polypeptide Polymers 0.000 claims 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims 11
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims 8
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 6
- 210000000612 antigen-presenting cell Anatomy 0.000 claims 5
- 210000000265 leukocyte Anatomy 0.000 claims 3
- 101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 claims 2
- 125000000539 amino acid group Chemical group 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 2
- 230000002163 immunogen Effects 0.000 claims 2
- 102000043129 MHC class I family Human genes 0.000 claims 1
- 108091054437 MHC class I family Proteins 0.000 claims 1
- 102000043131 MHC class II family Human genes 0.000 claims 1
- 108091054438 MHC class II family Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 108010017842 Telomerase Proteins 0.000 claims 1
- 102100032938 Telomerase reverse transcriptase Human genes 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 210000004443 dendritic cell Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 210000002433 mononuclear leukocyte Anatomy 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 210000005259 peripheral blood Anatomy 0.000 claims 1
- 239000011886 peripheral blood Substances 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11200698P | 1998-03-31 | 1998-03-31 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000541280A Division JP2002509716A (ja) | 1998-03-31 | 1999-03-30 | テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006353532A Division JP2007137889A (ja) | 1998-03-31 | 2006-12-27 | テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006020648A JP2006020648A (ja) | 2006-01-26 |
| JP2006020648A5 true JP2006020648A5 (cg-RX-API-DMAC7.html) | 2007-02-15 |
Family
ID=22341634
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000541280A Withdrawn JP2002509716A (ja) | 1998-03-31 | 1999-03-30 | テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物 |
| JP2005271209A Withdrawn JP2006020648A (ja) | 1998-03-31 | 2005-09-16 | テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物 |
| JP2006353532A Pending JP2007137889A (ja) | 1998-03-31 | 2006-12-27 | テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000541280A Withdrawn JP2002509716A (ja) | 1998-03-31 | 1999-03-30 | テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006353532A Pending JP2007137889A (ja) | 1998-03-31 | 2006-12-27 | テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6440735B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1068296B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2002509716A (cg-RX-API-DMAC7.html) |
| AU (1) | AU3456099A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2347067C (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999050392A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI990655A7 (fi) | 1996-10-01 | 1999-06-01 | Geron Corp | Ihmistelomeraasin katalyyttinen alayksikkö |
| US6444650B1 (en) * | 1996-10-01 | 2002-09-03 | Geron Corporation | Antisense compositions for detecting and inhibiting telomerase reverse transcriptase |
| US6093809A (en) * | 1996-10-01 | 2000-07-25 | University Technology Corporation | Telomerase |
| US6475789B1 (en) * | 1996-10-01 | 2002-11-05 | University Technology Corporation | Human telomerase catalytic subunit: diagnostic and therapeutic methods |
| US6261836B1 (en) * | 1996-10-01 | 2001-07-17 | Geron Corporation | Telomerase |
| US7585622B1 (en) | 1996-10-01 | 2009-09-08 | Geron Corporation | Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
| US6808880B2 (en) * | 1996-10-01 | 2004-10-26 | Geron Corporation | Method for detecting polynucleotides encoding telomerase |
| US7622549B2 (en) * | 1997-04-18 | 2009-11-24 | Geron Corporation | Human telomerase reverse transcriptase polypeptides |
| US20050013825A1 (en) * | 1997-04-18 | 2005-01-20 | Geron Corporation | Vaccine containing the catalytic subunit of telomerase for treating cancer |
| US7413864B2 (en) * | 1997-04-18 | 2008-08-19 | Geron Corporation | Treating cancer using a telomerase vaccine |
| US6337200B1 (en) * | 1998-03-31 | 2002-01-08 | Geron Corporation | Human telomerase catalytic subunit variants |
| CA2347067C (en) | 1998-03-31 | 2013-09-17 | Geron Corporation | Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer |
| US7402307B2 (en) | 1998-03-31 | 2008-07-22 | Geron Corporation | Method for identifying and killing cancer cells |
| US7030211B1 (en) | 1998-07-08 | 2006-04-18 | Gemvax As | Antigenic peptides derived from telomerase |
| US20020142974A1 (en) * | 1998-09-11 | 2002-10-03 | Leonard D. Kohn | Immune activation by double-stranded polynucleotides |
| ATE347904T1 (de) | 1998-10-29 | 2007-01-15 | Dana Farber Cancer Inst Inc | Krebsimmuntherapie und krebsdiagnose unter verwendung universeller tumorassoziierter antigene einschliesslich htert |
| EP1171612A2 (en) * | 1999-04-09 | 2002-01-16 | Biomira, Inc. | Telomerase-specific cancer vaccine |
| EP1257284A4 (en) * | 2000-02-15 | 2005-12-21 | Univ California | UNIVERSAL VACCINE AND METHOD OF TREATING CANCER USING TELOMERASE REVERSE TRANSCRIPTASE |
| WO2001060391A1 (en) | 2000-02-15 | 2001-08-23 | Regents Of The University Of California | A universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
| GB0031430D0 (en) | 2000-12-22 | 2001-02-07 | Norsk Hydro As | Polypeptides |
| AU2004224425B2 (en) * | 2003-02-06 | 2010-06-24 | Aduro Biotech | Modified free-living microbes, vaccine compositions and methods of use thereof |
| US7695725B2 (en) * | 2003-02-06 | 2010-04-13 | Aduro Biotech | Modified free-living microbes, vaccine compositions and methods of use thereof |
| ES2382332T3 (es) * | 2003-02-06 | 2012-06-07 | Aduro Biotech | Listeria atenuada para entrar en células no fagocíticas, vacunas que comprenden esta listeria y métodos de uso de las mismas |
| US7842289B2 (en) * | 2003-12-24 | 2010-11-30 | Aduro Biotech | Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof |
| CA2574802A1 (en) | 2004-07-20 | 2006-02-02 | Isogenis, Inc. | Specific inhibition of autoimmunity and diseases associated with autoantigens |
| CA2504451A1 (en) * | 2004-08-10 | 2006-02-10 | Geron Corporation | Dendritic cell vaccines for treating cancer made from embryonic stem cells |
| JPWO2006025525A1 (ja) * | 2004-09-03 | 2008-05-08 | 株式会社医学生物学研究所 | 樹状細胞において抗原提示されやすいタンパク質の選択方法 |
| EP1801202A4 (en) * | 2004-09-03 | 2008-02-06 | Medical & Biol Lab Co Ltd | METHOD FOR PRODUCING A DENDRITIC CELL WITH ACQUIRED CTL-INDUCING SKILL |
| ES2732623T3 (es) | 2005-01-06 | 2019-11-25 | Innate Pharma Sa | Tratamientos y métodos de combinación anti-KIR |
| NZ586780A (en) | 2005-03-23 | 2012-02-24 | Genmab As | Antibodies against CD38 for treatment of multiple myeloma |
| EP1748067A1 (en) * | 2005-07-29 | 2007-01-31 | Institut Pasteur | Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes |
| RU2309753C1 (ru) * | 2006-05-05 | 2007-11-10 | ЗАО "РеМеТэкс" | Комбинированный клеточный трансплантат на основе лимфокинактивированных киллеров и дендритных клеток, способ его получения и способ лечения и профилактики онкологических, инфекционных заболеваний и иммунодефицитных состояний |
| EP3753576A1 (en) | 2006-09-26 | 2020-12-23 | Genmab A/S | Combination treatment of cd38-expressing tumors |
| UA109633C2 (uk) | 2008-12-09 | 2015-09-25 | Антитіло людини проти тканинного фактора | |
| WO2010096693A2 (en) * | 2009-02-19 | 2010-08-26 | Mayo Foundation For Medical Education And Research | Methods and materials for generating t cells |
| US8563307B2 (en) | 2009-02-24 | 2013-10-22 | James Wang | Treatment of immunosuppression-related disorders |
| EP3581649A1 (en) | 2010-02-16 | 2019-12-18 | Ultimovacs ASA | Polypeptides |
| JP6055312B2 (ja) | 2010-03-10 | 2017-01-11 | ゲンマブ エー／エス | Ｃ−ｍｅｔに対するモノクローナル抗体 |
| CN107253992B (zh) | 2010-05-27 | 2022-03-11 | 根马布股份公司 | 针对her2的单克隆抗体 |
| CA2800769C (en) | 2010-05-27 | 2021-11-02 | Genmab A/S | Monoclonal antibodies against her2 epitope |
| RS59769B1 (sr) | 2010-06-09 | 2020-02-28 | Genmab As | Antitela protiv humanog cd38 |
| SMT201700547T1 (it) | 2010-06-15 | 2018-01-11 | Genmab As | Coniugati di farmaco anticorpo umano contro il fattore tissutale |
| US8679474B2 (en) * | 2010-08-04 | 2014-03-25 | StemBios Technologies, Inc. | Somatic stem cells |
| JP6177231B2 (ja) | 2011-04-20 | 2017-08-09 | ゲンマブ エー／エス | Ｈｅｒ２に対する二重特異性抗体 |
| CN103796677B (zh) | 2011-04-20 | 2019-08-16 | 健玛保 | 针对her2和cd3的双特异性抗体 |
| EP4520771A3 (en) | 2011-04-20 | 2025-07-16 | Genmab A/S | Bispecifc antibodies against her2 |
| TWI571513B (zh) | 2011-09-28 | 2017-02-21 | 幹細胞生物科技股份有限公司 | 體幹細胞及其製備方法 |
| US9155763B2 (en) | 2012-12-06 | 2015-10-13 | StemBios Technologies, Inc. | Lgr5+ somatic stem cells |
| EP2746770A1 (en) | 2012-12-21 | 2014-06-25 | Stembios Technologies, Inc. | Method for evaluating effect of action on subject based on stem celldynamics |
| US20170058043A1 (en) | 2014-12-06 | 2017-03-02 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Bispecific antibody for cancer immunotherapy |
| US11020465B2 (en) | 2016-03-04 | 2021-06-01 | The Trustees Of Columbia University In The City Of New York | Development of dual whole cell-based vaccine against pancreatic cancer |
| KR20190031573A (ko) * | 2016-08-02 | 2019-03-26 | 난트셀, 인크. | 수지상 세포들의 형질주입 및 그 방법들(transfection of dendritic cells and methods therefor) |
| EP3518955A4 (en) * | 2016-09-30 | 2020-10-07 | The Wistar Institute Of Anatomy And Biology | TERT-IMMUNOGENIC COMPOSITIONS AND METHODS OF TREATMENT THEREOF |
| EP3585403A4 (en) | 2017-02-22 | 2020-12-09 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | CHEMERICAL ANTIGENIC RECEPTORS BINDING TO TIM3 |
| MX2019015484A (es) | 2017-07-07 | 2020-07-28 | H Lee Moffitt Cancer Ct & Res | Receptores quiméricos de antígeno con dominios coestimuladores cd28 mutados. |
| AU2019205422B2 (en) | 2018-01-08 | 2025-08-28 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Compositions and methods for targeting CD99-expressing cancers |
| US11951129B2 (en) | 2018-01-09 | 2024-04-09 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Compositions and methods for targeting CLEC12A-expressing cancers |
| CN115315260A (zh) | 2019-12-02 | 2022-11-08 | 新基公司 | 治疗癌症的疗法 |
| WO2021174055A1 (en) | 2020-02-27 | 2021-09-02 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Tumor-infiltrating lymphocytes with enhanced tumor reactivity |
| EP4146697A1 (en) | 2020-05-05 | 2023-03-15 | Regeneron Pharmaceuticals, Inc. | Car comprising cd28 zeta and cd3 zeta |
| WO2024206155A1 (en) | 2023-03-24 | 2024-10-03 | Cornell University | Utilizing t cells derived from tumor draining lymph nodes for chimeric antigen receptor (car) t cell therapy for the treatment of cancer |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3483252D1 (de) | 1983-12-05 | 1990-10-25 | Asahi Chemical Ind | Verfahren zur induktion von antitumorimmunozyten, verfahren zur herstellung von antitumorimmunozyten und durch das verfahren hergestellte antitumorimmunozyten. |
| US6004807A (en) | 1992-03-30 | 1999-12-21 | Schering Corporation | In vitro generation of human dendritic cells |
| AU687733B2 (en) | 1992-04-01 | 1998-03-05 | Rockefeller University, The | Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens |
| JP3649335B2 (ja) | 1992-04-01 | 2005-05-18 | ザ ロックフェラー ユニバーシティー | 樹枝状細胞前駆体のインビトロ増殖の方法およびその免疫原製造への使用 |
| IL105503A (en) | 1992-04-28 | 1999-05-09 | Astra Ab | Carbon peptide couplets capable of eliciting an immune response of T cells |
| US5639613A (en) | 1992-05-13 | 1997-06-17 | Board Of Regents, University Of Texas System | Methods for cancer diagnosis and prognosis |
| US5489508A (en) | 1992-05-13 | 1996-02-06 | University Of Texas System Board Of Regents | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| US5648215A (en) | 1992-05-13 | 1997-07-15 | Board Of Regents, The University Of Texas System | Telomerase diagnostic methods |
| US5645986A (en) * | 1992-05-13 | 1997-07-08 | Board Of Reagents, The University Of Texas System | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| US5629154A (en) | 1993-11-12 | 1997-05-13 | Geron Corporation | Telomerase activity assays |
| US5587308A (en) | 1992-06-02 | 1996-12-24 | The United States Of America As Represented By The Department Of Health & Human Services | Modified adeno-associated virus vector capable of expression from a novel promoter |
| AU4678993A (en) * | 1992-07-16 | 1994-02-14 | Board Of Trustees Of The Leland Stanford Junior University | Methods for using dendritic cells to activate t cells |
| US6077519A (en) | 1993-01-29 | 2000-06-20 | University Of Pittsburgh | Methods for isolation and use of T cell epitopes eluted from viable cells in vaccines for treating cancer patients |
| WO1994021287A1 (en) | 1993-03-15 | 1994-09-29 | The Government Of The United States Of America As Represented By The Department Of Health And Human Services | Peptide coated dendritic cells as immunogens |
| JPH08509606A (ja) * | 1993-04-20 | 1996-10-15 | ロビンソン，ウィリアム エス． | 細胞内感染因子に感染した個体を処置する方法および物質 |
| IT1264516B1 (it) | 1993-05-31 | 1996-09-24 | Biotop Sas Di Rita Cassarin | Cellule dendritiche immortalizzate |
| DE4412794A1 (de) | 1994-04-14 | 1995-12-14 | Univ Ludwigs Albert | Verfahren zur Herstellung von dendritischen Zellen, so erhaltene Zellen und Behälter zur Durchführung dieses Verfahrens |
| AU710783B2 (en) | 1994-06-14 | 1999-09-30 | Board Of Trustees Of The Leland Stanford Junior University | Methods for in vivo T cell activation by antigen-pulsed dendritic cells |
| US5972627A (en) | 1994-06-15 | 1999-10-26 | Systemix, Inc. | Method of purifying a population of cells enriched for dendritic and/or lymphoid progenitors and populations of cells obtained thereby |
| JP3680219B2 (ja) | 1994-06-28 | 2005-08-10 | 独立行政法人理化学研究所 | 癌細胞障害性ｔリンパ球の誘導培養方法 |
| US5583016A (en) | 1994-07-07 | 1996-12-10 | Geron Corporation | Mammalian telomerase |
| US5648219A (en) | 1995-06-07 | 1997-07-15 | Zymogenetics, Inc. | Immortalized dendritic cells |
| US6010905A (en) | 1995-01-27 | 2000-01-04 | The United States Of America As Represented By The Department Of Health & Human Services | Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells |
| US5643786A (en) | 1995-01-27 | 1997-07-01 | The United States Of America As Represented By The Department Of Health And Human Services | Method for isolating dendritic cells |
| US5871728A (en) | 1995-03-31 | 1999-02-16 | University Of Pittsburgh | Method of regulating dendritic cell maturation |
| US5656638A (en) * | 1995-04-18 | 1997-08-12 | Geron Corporation | Telomerase inhibitors |
| US6015554A (en) | 1995-06-07 | 2000-01-18 | Systemix, Inc. | Method of reconstituting human lymphoid and dendritic cells |
| US5788963A (en) | 1995-07-31 | 1998-08-04 | Pacific Northwest Cancer Foundation | Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| US5968506A (en) * | 1995-08-04 | 1999-10-19 | Geron Corporation | Purified telomerase |
| WO1997007200A1 (en) | 1995-08-16 | 1997-02-27 | The Board Of Trustees Of The Leland Stanford Junior University | Adult oligodendrocyte precursor cell compositions and methods |
| US5858777A (en) | 1995-09-08 | 1999-01-12 | Geron Corporation | Methods and reagents for regulating telomere length and telomerase activity |
| AU1152397A (en) * | 1995-12-20 | 1997-07-14 | Board Of Trustees Of The Leland Stanford Junior University | Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
| US6080409A (en) | 1995-12-28 | 2000-06-27 | Dendreon Corporation | Immunostimulatory method |
| WO1997024447A1 (en) | 1996-01-02 | 1997-07-10 | Chiron Corporation | Immunostimulation mediated by gene-modified dendritic cells |
| US6224870B1 (en) * | 1997-01-24 | 2001-05-01 | Genitrix, Ltd. | Vaccine compositions and methods of modulating immune responses |
| DE69734974D1 (de) | 1996-02-08 | 2006-02-02 | Us Gov Health & Human Serv | Verfahren zur transformation dendritischer zellen und aktivierung von t zellen |
| US7659119B2 (en) | 1996-02-12 | 2010-02-09 | Argos Therapeutics, Inc. | Method and compositions for obtaining mature dendritic cells |
| EP0906444A1 (de) | 1996-04-19 | 1999-04-07 | Gabriele Pecher | Gentransfizierte humane dendritische zellen, ihre herstellung und ihre verwendung, bevorzugt als vakzine |
| US5853719A (en) | 1996-04-30 | 1998-12-29 | Duke University | Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| US5747317A (en) | 1996-07-08 | 1998-05-05 | Tularik Inc. | Human telomerase RNA interacting protein gene |
| US5770422A (en) | 1996-07-08 | 1998-06-23 | The Regents Of The University Of California | Human telomerase |
| IL127912A0 (en) | 1996-07-10 | 1999-11-30 | Immunex Corp | Method of activating dendritic cells |
| US6017527A (en) | 1996-07-10 | 2000-01-25 | Immunex Corporation | Activated dendritic cells and methods for their activation |
| WO1998007838A1 (en) | 1996-08-21 | 1998-02-26 | Mitsubishi Chemical Corporation | Higher animal telomerase protein and gene encoding the same |
| FI990655A7 (fi) * | 1996-10-01 | 1999-06-01 | Geron Corp | Ihmistelomeraasin katalyyttinen alayksikkö |
| US6261836B1 (en) * | 1996-10-01 | 2001-07-17 | Geron Corporation | Telomerase |
| CH689672A9 (de) | 1996-10-01 | 2000-02-29 | Geron Corp | Katalytische Untereinheit menschlicher Telomerase. |
| US6093809A (en) | 1996-10-01 | 2000-07-25 | University Technology Corporation | Telomerase |
| US5812477A (en) | 1996-10-03 | 1998-09-22 | Micron Technology, Inc. | Antifuse detection circuit |
| WO1998014561A1 (en) | 1996-10-04 | 1998-04-09 | Becton Dickinson And Company | Identification of a cd34+ bone marrow precursor for dendritic cells in blood and lymphoid tissues |
| EP0931138A4 (en) | 1996-10-10 | 2003-04-09 | Univ Duke | METHOD FOR PRODUCING A THYMIC MICRO ENVIRONMENT TO SUPPORT DENDRITIC CELL DEVELOPMENT |
| US7390891B1 (en) | 1996-11-15 | 2008-06-24 | Amgen Inc. | Polynucleotides encoding a telomerase component TP2 |
| US5962318A (en) | 1996-11-15 | 1999-10-05 | St. Jude Children's Research Hospital | Cytotoxic T lymphocyte-mediated immunotherapy |
| US5919656A (en) | 1996-11-15 | 1999-07-06 | Amgen Canada Inc. | Genes encoding telomerase protein 1 |
| EP0942991A2 (en) | 1996-11-26 | 1999-09-22 | Baylor College Of Medicine | Identification of inhibitors that prevent access of telomerase to chromosomal terminus |
| WO1998037181A2 (en) | 1997-02-20 | 1998-08-27 | Whitehead Institute For Biomedical Research | Telomerase catalytic subunit gene and encoded protein |
| CA2286819A1 (en) | 1997-04-17 | 1998-10-22 | Flossie Wong-Staal | Use of lentiviral vectors for antigen presentation in dendritic cells |
| AUPO723097A0 (en) | 1997-06-06 | 1997-07-03 | Australian National University, The | A method for culturing cells |
| WO1998059040A2 (de) | 1997-06-20 | 1998-12-30 | Bayer Aktiengesellschaft | Humane katalytische telomerase-untereinheit und deren diagnostische und therapeutische verwendung |
| CA2296008A1 (en) | 1997-06-25 | 1998-12-30 | The Regents Of The University Of California | Rice beta-glucanase enzymes and genes |
| AU748442B2 (en) | 1997-07-01 | 2002-06-06 | Cambia | Vertebrate telomerase genes and proteins and uses thereof |
| AU1220599A (en) | 1997-11-14 | 1999-06-07 | Hemosol Inc. | Method for the production and use of dendritic cells |
| CA2347067C (en) | 1998-03-31 | 2013-09-17 | Geron Corporation | Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer |
| WO1999051255A1 (en) | 1998-04-06 | 1999-10-14 | The Johns Hopkins University School Of Medicine | Telomerase-associated proteins |
| NZ508936A (en) | 1998-06-02 | 2005-01-28 | Dendreon Corp | Method for preparation and in vivo administration of antigen presenting cell composition |
| US6277613B1 (en) | 1998-06-10 | 2001-08-21 | The Rockefeller University | TRF1 binding protein, methods of use thereof |
| WO1999063945A2 (en) | 1998-06-12 | 1999-12-16 | Sloan-Kettering Institute For Cancer Research | Vaccination strategy to prevent and treat cancers |
| US7030211B1 (en) | 1998-07-08 | 2006-04-18 | Gemvax As | Antigenic peptides derived from telomerase |
| GB9816781D0 (en) | 1998-07-31 | 1998-09-30 | Univ London | Herpes virus vectors for dendritic cells |
| CA2343355A1 (en) | 1998-09-15 | 2000-03-23 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | In situ injection of antigen-presenting cells with genetically enhanced cytokine expression |
| ATE347904T1 (de) | 1998-10-29 | 2007-01-15 | Dana Farber Cancer Inst Inc | Krebsimmuntherapie und krebsdiagnose unter verwendung universeller tumorassoziierter antigene einschliesslich htert |
| GB9824306D0 (en) | 1998-11-05 | 1998-12-30 | Isis Innovation | Method for producing dendritic dells |
| EP1171612A2 (en) * | 1999-04-09 | 2002-01-16 | Biomira, Inc. | Telomerase-specific cancer vaccine |
-
1999
- 1999-03-30 CA CA2347067A patent/CA2347067C/en not_active Expired - Lifetime
- 1999-03-30 EP EP99916193A patent/EP1068296B1/en not_active Expired - Lifetime
- 1999-03-30 AU AU34560/99A patent/AU3456099A/en not_active Abandoned
- 1999-03-30 WO PCT/US1999/006898 patent/WO1999050392A1/en not_active Ceased
- 1999-03-30 JP JP2000541280A patent/JP2002509716A/ja not_active Withdrawn
-
2000
- 2000-09-29 US US09/675,321 patent/US6440735B1/en not_active Expired - Lifetime
-
2005
- 2005-09-16 JP JP2005271209A patent/JP2006020648A/ja not_active Withdrawn
-
2006
- 2006-12-27 JP JP2006353532A patent/JP2007137889A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006020648A5 (cg-RX-API-DMAC7.html) | ||
| AU2023241320B2 (en) | Neoantigens and methods of their use | |
| Unanue et al. | The basis for the immunoregulatory role of macrophages and other accessory cells | |
| ES2869155T3 (es) | Péptidos inmunogénicos para su uso en la prevención y/o tratamiento de enfermedades infecciosas, enfermedades autoinmunitarias, respuestas inmunitarias a alofactores, enfermedades alérgicas, tumores, rechazo de injerto y respuestas inmunitarias contra vectores virales usados para terapia génica o vacunación génica | |
| JP2020506690A5 (cg-RX-API-DMAC7.html) | ||
| US20070248584A1 (en) | Immunomodulating Compositions, Uses Therefore and Processes for Their Production | |
| JP2010500399A5 (cg-RX-API-DMAC7.html) | ||
| JP2008530245A5 (cg-RX-API-DMAC7.html) | ||
| JP2013522302A (ja) | 酵母系免疫療法を使用した感染症の薬理ゲノミクス及び治療反応性ガイド治療 | |
| US20120135016A1 (en) | Induction of neurogenesis and stem cell therapy in combination with copolymer 1 | |
| MXPA06004566A (es) | Composicion inmunogenica y metodo para desarrollar una vacuna basada en la proteina de fusion. | |
| CN101951931A (zh) | 免疫调节组合物和其用途 | |
| JP2006502228A5 (cg-RX-API-DMAC7.html) | ||
| JP2006515744A5 (cg-RX-API-DMAC7.html) | ||
| HK141594A (en) | Peptide fragments of HIV and their use in vaccines and diagnosis | |
| KR20080042097A (ko) | 수포에 담긴 불완전 리보솜 생성물（ＤＲｒｉｂｂｌｅ） 및면역 반응을 자극하기 위해 이를 이용하는 방법 | |
| WO2006124412A2 (en) | Methods for the rapid expansion of antigen specific t-cells | |
| JP2012526519A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2008065752A1 (ja) | ｄｉＲＮＡを有効成分とする免疫治療用薬剤 | |
| JP2007509063A5 (cg-RX-API-DMAC7.html) | ||
| JPH11509521A (ja) | エンベロープ化ウイルスに対する多能性ワクチン | |
| WO2013103362A1 (en) | Antigen-presenting platelets and methods of eliciting an immune response | |
| JP2013512659A5 (cg-RX-API-DMAC7.html) | ||
| CN1832960B (zh) | 免疫调节组合物,其用途及生产方法 | |
| WO2005039632B1 (en) | Colorectal cancer antigen |